WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New ATC

List of new ATC codes decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC codes should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new ATC codes will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

 

ATC codeATC level name (INN/generic name)Deadline for objection to temporary code Implementation in the ATC/DDD index
A05AA04obeticholic acid01.02.20152016
A08AA62bupropion and naltrexone01.02.20152016
A10AE56insulin degludec and liraglutide01.02.20152016
A10BD20metformin and empagliflozin01.02.20152016
A16AB13asfotase alfa01.02.20152016
A16AB14sebelipase alfa01.02.20152016
C10BX10rosuvastatin and valsartan01.02.20152016
D01AC18luliconazole01.02.20152016
D01AC19efinaconazole01.02.20152016
G03AC10drospirenone01.02.20152016
J01DI54ceftolozane and enzyme inhibitor01.02.20152016
J01MB08nemonoxacin01.02.20152016
J01XX11tedizolid01.02.20152016
J02AC05isavuconazole01.02.20152016
J05AR15atazanavir and cobicistat01.02.20152016
J05AR16lamivudine and raltegravir01.02.20152016
J05AR17emtricitabine and tenofovir alafenamide01.02.20152016
J05AR18emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat01.02.20152016
J05AX16dasabuvir01.02.20152016
J05AX65sofosbuvir and ledipasvir01.02.20152016
J05AX66dasabuvir, ombitasvir, paritaprevir and ritonavir 01.02.20152016
J05AX67ombitasvir, paritaprevir and ritonavir 01.02.20152016
J07BM03papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)01.02.20152016
J07BX01smallpox, live attenuated01.02.20152016
L01XC17nivolumab01.02.20152016
L01XC18pembrolizumab01.02.20152016
L01XC19blinatumomab01.02.20152016
L01XE29lenvatinib01.02.20152016
L01XE31nintedanib01.02.20152016
L01XX48sonidegib01.02.20152016
L01XX49belinostat01.02.20152016
M09AX03ataluren01.02.20152016
N03AX23brivaracetam01.02.20152016
N05CH03tasimelteon01.02.20152016
N07XX11pitolisant01.02.20152016
P03AX06benzyl alcohol01.02.20152016
R02AA21octenidine01.02.20152016
R03AL06olodaterol and tiotropiumbromide01.02.20152016
S01XA23sirolimus01.02.20152016

Last updated: 2014-12-09